Spectrum Pharmaceuticals Inc Announces Additional Extension Of Tender Offer Period For Shares Of Allos Therapeutics, Inc.

Spectrum Pharmaceuticals Inc and Allos Therapeutics, Inc. announced that Spectrum has provided an additional extension of the offer period in connection with tender offer to purchase all of the outstanding shares of common stock of Allos for $1.82 per share in cash, without interest and less any...

Friday, 3 Aug 2012 07:05pm EDT

FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer-Reuters

Reuters reported that the U.S. Food and Drug Administration has approved Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for use in combination with a folinic acid, fluorouracil and irinotecan chemotherapy regimen to treat adults with colorectal cancer.

Friday, 3 Aug 2012 11:05am EDT

Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences

Glaxosmithkline Plc announced that it has completed its acquisition of Human Genome Sciences for USD3.6 billion on an equity basis, or approximately USD3 billion net of cash and debt. All outstanding shares of HGS were acquired for USD14.25 per share in cash. Pursuant to the terms of the merger...

Friday, 3 Aug 2012 02:00am EDT

Glenmark Pharmaceuticals Ltd Announces Demise of Chairman Emeritus

Glenmark Pharmaceuticals Ltd announced that Mr. Gracias Saldanha, Founder and Chairman Emeritus of the Company passed away on July 21, 2012.

Thursday, 2 Aug 2012 08:30am EDT
» More General

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Energy +48.60%
Basic Materials +148.75%
Industrials +66.08%
Cyclical Goods & Services +67.38%
Non-Cyclical Goods & Services +59.96%
Financials +72.07%
Healthcare +40.18%
Technology +16.35%
Telecoms +115.37%
Utilities +68.48%

Market News

» More News

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

» View All Earnings Announcements

Analyst Research

Report Title Price
PLETHORA SOLUTIONS HOLDINGS - STAYING THE COURSE
Provider: Edison Investment Research
$10.00
Buy
PLETHORA SOLUTIONS HOLDINGS - WOMEN'S HEALTH PROGRESS
Provider: Edison Investment Research
$10.00
Buy
PLETHORA SOLUTIONS HOLDINGS - INTO PHASE III
Provider: Edison Investment Research
$10.00
Buy
PLETHORA SOLUTIONS - PAUL CAPITAL FINANCING
Provider: Edison Investment Research
$10.00
Buy
PLETHORA SOLUTIONS - LATE-STAGE PROGRESS
Provider: Edison Investment Research
$10.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.